Arsenic-based therapy shown to help eradicate leukemia-initiatin...

Courtesy EurekAlert! - Medicine and Health  Sun, 05/11/2008 - 23:00

(Beth Israel Deaconess Medical Center) In a paradoxical discovery, a research team led by investigators at Beth Israel Deaconess Medical Center has found that a tumor suppressor protein known as PML appears to be the factor that enables leukemia initiating cells to maintain their quiescence -- the inert state that protects them from being destroyed by cancer therapies.


 

More related items

A new gene trigger for pregnancy disorder identified
(Beth Israel Deaconess Medical Center) The COMT gene -- known already for its role in schizophrenia -- has been found to play a role in preeclampsia,...

Study shows positive findings in treating patients with...
(Beth Israel Deaconess Medical Center) The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease...

How Much Does a CT Scan Cost?
Are you shopping around for a CT scan but have no idea how much your out-of-pocket costs will be? You are not alone. A new type of CT scan, called...

Pond scum could be key to new cancer therapies
(University of Illinois at Chicago) Researchers at the University of Illinois at Chicago College of Pharmacy are collaborating with the Ohio State...

A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...

What Your Doctor May Not Tell You About Fibromyalgia: The...
In this book Dr. R. Paul St. Amand offers the first effective protocol to help reverse the autoimmune disorder, Fibromyalgia, in children. The...

Good Calories, Bad Calories
In this groundbreaking book, the result of seven years of research in every science connected with the impact of nutrition on health, award-winning...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com